NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1,212 Cr | ₹849 Cr | ₹47 Cr | ₹299 Cr | ₹417 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹1,212 Cr |
Mar2023 | ₹849 Cr |
Mar2022 | ₹47 Cr |
Mar2021 | ₹299 Cr |
Mar2020 | ₹417 Cr |
How is Cash Flow from Operating Activities of NATCO PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹1,212 Cr | 42.69 | |
Mar2023 | ₹849 Cr | 1,726.02 | |
Mar2022 | ₹47 Cr | -84.44 | |
Mar2021 | ₹299 Cr | -28.40 | |
Mar2020 | ₹417 Cr | - |
Compare Cash Flow from Operating Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹13,984.1 Cr | -5.4% | -37.1% | -22.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,012.0 Cr | 4.6% | -0.9% | 5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,188.0 Cr | 0.5% | -5.5% | 57.2% | Stock Analytics | |
CIPLA | ₹118,041.0 Cr | 0.2% | 0.6% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,512.0 Cr | -0.4% | -1.5% | 14.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,445.1 Cr | -2.2% | -8.6% | -13.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -5.4% |
-37.1% |
-22.6% |
SENSEX | -0.7% |
-4.5% |
-0.4% |
You may also like the below Video Courses